Literature DB >> 20869727

Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later.

John A Morrison1, Charles J Glueck, Stephen Daniels, Ping Wang, Davis Stroop.   

Abstract

OBJECTIVE: To evaluate the relationships of adiponectin levels at age 16 years in obese schoolgirls to metabolic syndrome and its components at age 23 years. STUDY
DESIGN: Seven-year prospective study of 381 females.
RESULTS: In 144 white and 129 black non-obese 16-year old girls (body mass index < 24.6 kg/m(2)), race-specific median adiponectin levels (white 12 mg/L, black 11) was used to identify paradoxically high adiponectin levels in obese girls. Of 34 white and 74 black obese girls, 12 (35%) and 19 (26%) had paradoxically high adiponectin levels. In these 108 obese girls, adiponectin levels at age 16 years independently predicted high-density lipoprotein cholesterol (positive) and waist (negative), insulin (negative), and glucose (negative) at age 23 years; paradoxically high adiponectin levels at age 16 years was a negative independent predictor for waist, homeostatic model assessment-insulin resistance, and for the number of abnormal components of the metabolic syndrome at age 23 years. In 31 pairs of obese girls with and without paradoxically high adiponectin levels, matched by race and age 16 body mass index, adiponectin levels at age 16 years was a negative predictor for the number of abnormal metabolic syndrome components at age 23 years.
CONCLUSION: Paradoxically high adiponectin levels in obese 16 year old girls protects against metabolic syndrome and its components at age 23 years.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869727      PMCID: PMC3022119          DOI: 10.1016/j.jpeds.2010.08.012

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  44 in total

1.  More powerful procedures for multiple significance testing.

Authors:  Y Hochberg; Y Benjamini
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

2.  Can we identify metabolically healthy but obese individuals (MHO)?

Authors:  A D Karelis; M Brochu; R Rabasa-Lhoret
Journal:  Diabetes Metab       Date:  2004-12       Impact factor: 6.041

3.  Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services.

Authors:  S E Barlow; W H Dietz
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

Review 4.  Normal growth and techniques of growth assessment.

Authors:  J M Tanner
Journal:  Clin Endocrinol Metab       Date:  1986-08

5.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

6.  Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study.

Authors: 
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

7.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Authors:  Joan Vendrell; Montserrat Broch; Nuria Vilarrasa; Ana Molina; Jose Manuel Gómez; Cristina Gutiérrez; Immaculada Simón; Joan Soler; Cristóbal Richart
Journal:  Obes Res       Date:  2004-06

8.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

Authors:  Claudia Menzaghi; Tonino Ercolino; Rosa Di Paola; Anders H Berg; James H Warram; Philipp E Scherer; Vincenzo Trischitta; Alessandro Doria
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  Development of a prediction equation for insulin sensitivity from anthropometry and fasting insulin in prepubertal and early pubertal children.

Authors:  Terry T-K Huang; Maria S Johnson; Michael I Goran
Journal:  Diabetes Care       Date:  2002-07       Impact factor: 19.112

10.  Adiponectin before and after weight loss in obese children.

Authors:  T Reinehr; C Roth; T Menke; W Andler
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  9 in total

Review 1.  Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.

Authors:  Mark D DeBoer
Journal:  Nutrition       Date:  2012-09-28       Impact factor: 4.008

2.  Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans.

Authors:  Ayo P Doumatey; Amy R Bentley; Jie Zhou; Hanxia Huang; Adebowale Adeyemo; Charles N Rotimi
Journal:  J Endocrinol Metab       Date:  2012-04-01

3.  Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.

Authors:  Ioannis Kyrou; Olga Tsantarlioti; Demosthenes B Panagiotakos; Constantine Tsigos; Ekavi Georgousopoulou; Christina Chrysohoou; Ioannis Skoumas; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

4.  Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents.

Authors:  P Li; R Jiang; L Li; C Liu; F Yang; Y Qiu
Journal:  Eur J Clin Nutr       Date:  2014-07-30       Impact factor: 4.016

Review 5.  Bone Response to Weight Loss Following Bariatric Surgery.

Authors:  Chiara Mele; Marina Caputo; Alice Ferrero; Tommaso Daffara; Beatrice Cavigiolo; Daniele Spadaccini; Antonio Nardone; Flavia Prodam; Gianluca Aimaretti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

6.  Relationships between osteocalcin, glucose metabolism, and adiponectin in obese children: Is there crosstalk between bone tissue and glucose metabolism?

Authors:  Nilay Abseyi; Zeynep Şıklar; Merih Berberoğlu; Bülent Hacıhamdioğlu; Şenay Savaş Erdeve; Gönül Öçal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-12

Review 7.  Metabolic disturbances connecting obesity and depression.

Authors:  Cecile Hryhorczuk; Sandeep Sharma; Stephanie E Fulton
Journal:  Front Neurosci       Date:  2013-10-07       Impact factor: 4.677

Review 8.  Mood, food, and obesity.

Authors:  Minati Singh
Journal:  Front Psychol       Date:  2014-09-01

9.  Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.

Authors:  M D DeBoer; M J Gurka; J A Morrison; J G Woo
Journal:  Int J Obes (Lond)       Date:  2016-05-02       Impact factor: 5.095

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.